About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Col4a3tm1Dec
targeted mutation 1, Dominic Cosgrove
MGI:1857432
Summary 6 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Col4a3tm1Dec/Col4a3tm1Dec 129-Col4a3tm1Dec/J MGI:4452030
hm2
Col4a3tm1Dec/Col4a3tm1Dec 129X1/SvJ-Col4a3tm1Dec MGI:3510458
hm3
Col4a3tm1Dec/Col4a3tm1Dec B6.129X1-Col4a3tm1Dec MGI:4868448
hm4
Col4a3tm1Dec/Col4a3tm1Dec involves: 129X1/SvJ * C57BL/6 MGI:3510446
cx5
Col4a3tm1Dec/Col4a3tm1Dec
Itga1tm1Gdnr/Itga1tm1Gdnr
involves: 129S4/SvJae * 129X1/SvJ * BALB/c MGI:3583734
cx6
Col4a3tm1Dec/Col4a3tm1Dec
Sostdc1tm1Myan/Sostdc1tm1Myan
involves: 129X1/SvJ MGI:4452039


Genotype
MGI:4452030
hm1
Allelic
Composition
Col4a3tm1Dec/Col4a3tm1Dec
Genetic
Background
129-Col4a3tm1Dec/J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Col4a3tm1Dec mutation (1 available); any Col4a3 mutation (9 available)
phenotype observed in females
phenotype observed in males
N normal phenotype

Sostdc1tm1Myan/Sostdc1tm1Myan Col4a3tm1Dec/Col4a3tm1Dec mice show less glomerular and tubular injury than Col4a3tm1Dec/Col4a3tm1Dec mice

mortality/aging
• impaired survival compared to Col4a3tm1Dec Sostdc1tm1Myan double homozygotes beyond 13 weeks of age (J:158731)
• impaired survival compared to Col4a3tm1Dec Sostdc1tm1Myan double homozygotes beyond 13 weeks of age (J:158731)
• impaired survival compared to Col4a3tm1Dec Sostdc1tm1Myan double homozygotes beyond 13 weeks of age (J:158731)
• impaired survival compared to Col4a3tm1Dec Sostdc1tm1Myan double homozygotes beyond 13 weeks of age (J:158731)

renal/urinary system
• intraglomerular hemorrhage at 6 weeks of age (J:158731)
• intraglomerular hemorrhage at 6 weeks of age (J:158731)
• at 5 weeks of age, proteinuria is initiated (J:158731)
• at 5 weeks of age, proteinuria is initiated (J:158731)
• irregular thickening and splitting of the glomerular basement membrane at 4 weeks of age by electron microscopy (J:158731)
• irregular thickening and splitting of the glomerular basement membrane at 4 weeks of age by electron microscopy (J:158731)
• irregular thickening at 4 weeks of age (J:158731)
• irregular thickening at 4 weeks of age (J:158731)
• at 6 weeks of age, minor glomerular lesions are occasionally observed by light microscopy (J:158731)
• at 6 weeks of age, minor glomerular lesions are occasionally observed by light microscopy (J:158731)
• progressive glomerulonephritis (J:158731)
• progressive glomerulonephritis (J:158731)
• segmental sclerosis at 6 weeks of age (J:158731)
• at 10 weeks of age mice demonstrate glomerulosclerosis associated with inflammatory cell infiltration, interstitial fibrosis, tubular atrophy, and cast formation (J:158731)
• segmental sclerosis at 6 weeks of age (J:158731)
• at 10 weeks of age mice demonstrate glomerulosclerosis associated with inflammatory cell infiltration, interstitial fibrosis, tubular atrophy, and cast formation (J:158731)
• at 10 weeks of age, severe glomerular lesions associated with tubulointerstitial fibrosis are observed (J:158731)
• at 10 weeks of age, severe glomerular lesions associated with tubulointerstitial fibrosis are observed (J:158731)
• at 10 weeks of age mice demonstrate tubular atrophy (J:158731)
• at 10 weeks of age mice demonstrate tubular atrophy (J:158731)
• renal cast formation at 10 weeks of age (J:158731)
• renal cast formation at 10 weeks of age (J:158731)
• at 10 weeks of age renal function is deteriorating (J:158731)
• at 10 weeks of age renal function is deteriorating (J:158731)

homeostasis/metabolism
• at 10 weeks of age (J:158731)
• at 10 weeks of age (J:158731)
• at 10 weeks of age (J:158731)
• at 10 weeks of age (J:158731)
• at 5 weeks of age, proteinuria is initiated (J:158731)
• at 5 weeks of age, proteinuria is initiated (J:158731)

immune system
• progressive glomerulonephritis (J:158731)
• progressive glomerulonephritis (J:158731)

cardiovascular system
• intraglomerular hemorrhage at 6 weeks of age (J:158731)
• intraglomerular hemorrhage at 6 weeks of age (J:158731)

Mouse Models of Human Disease
OMIM ID Ref(s)
Alport Syndrome, Autosomal Recessive 203780 J:158731




Genotype
MGI:3510458
hm2
Allelic
Composition
Col4a3tm1Dec/Col4a3tm1Dec
Genetic
Background
129X1/SvJ-Col4a3tm1Dec
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Col4a3tm1Dec mutation (1 available); any Col4a3 mutation (9 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hearing/vestibular/ear
• as early as 6 weeks, homozygotes display significant thickening of the strial capillary basement membrane (SCBM) (J:91619)
• as early as 6 weeks, homozygotes display significant thickening of the strial capillary basement membrane (SCBM) (J:91619)
• at 7-9 weeks of age (i.e. prior to end-stage renal disease), SCBM thickening is associated with significantly elevated matrix metalloproteinases (MMP) deposition (J:98449)
• treatment with an inhibitor of MMP-2, -9, -12, and -14 exacerbates SCBM thickening, directly implicating altered basement membrane metabolism in maintaining normal SCBM composition and thickness (J:98449)
• at 7-9 weeks of age (i.e. prior to end-stage renal disease), SCBM thickening is associated with significantly elevated matrix metalloproteinases (MMP) deposition (J:98449)
• treatment with an inhibitor of MMP-2, -9, -12, and -14 exacerbates SCBM thickening, directly implicating altered basement membrane metabolism in maintaining normal SCBM composition and thickness (J:98449)
• at 7-9 weeks of age (i.e. prior to end-stage renal disease), homozygotes show matrix metalloproteinase dysregulation in the stria vascularis (J:98449)
• at 7-9 weeks of age (i.e. prior to end-stage renal disease), homozygotes show matrix metalloproteinase dysregulation in the stria vascularis (J:98449)
• as early as 6 weeks, homozygotes display significant thickening of the strial capillary basement membrane (SCBM) (J:91619)
• as early as 6 weeks, homozygotes display significant thickening of the strial capillary basement membrane (SCBM) (J:91619)
• at 6-8 weeks of age, auditory-evoked brainstem response measurements suggest a small increase in auditory thresholds across all frequencies tested with successive measurements on individual mutant mice (J:91619)
• at 6-8 weeks of age, auditory-evoked brainstem response measurements suggest a small increase in auditory thresholds across all frequencies tested with successive measurements on individual mutant mice (J:91619)
• homozygotes display a moderate, high frequency, progressive sensorineural hearing loss (J:91619)
• homozygotes display a moderate, high frequency, progressive sensorineural hearing loss (J:91619)

cardiovascular system
• as early as 6 weeks, homozygotes display significant thickening of the strial capillary basement membrane (SCBM) (J:91619)
• as early as 6 weeks, homozygotes display significant thickening of the strial capillary basement membrane (SCBM) (J:91619)

cellular
• as early as 6 weeks, homozygotes display significant thickening of the strial capillary basement membrane (SCBM) (J:91619)
• as early as 6 weeks, homozygotes display significant thickening of the strial capillary basement membrane (SCBM) (J:91619)
• at 7-9 weeks of age (i.e. prior to end-stage renal disease), SCBM thickening is associated with significantly elevated matrix metalloproteinases (MMP) deposition (J:98449)
• treatment with an inhibitor of MMP-2, -9, -12, and -14 exacerbates SCBM thickening, directly implicating altered basement membrane metabolism in maintaining normal SCBM composition and thickness (J:98449)
• at 7-9 weeks of age (i.e. prior to end-stage renal disease), SCBM thickening is associated with significantly elevated matrix metalloproteinases (MMP) deposition (J:98449)
• treatment with an inhibitor of MMP-2, -9, -12, and -14 exacerbates SCBM thickening, directly implicating altered basement membrane metabolism in maintaining normal SCBM composition and thickness (J:98449)

Mouse Models of Human Disease
OMIM ID Ref(s)
Alport Syndrome, Autosomal Recessive 203780 J:91619




Genotype
MGI:4868448
hm3
Allelic
Composition
Col4a3tm1Dec/Col4a3tm1Dec
Genetic
Background
B6.129X1-Col4a3tm1Dec
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Col4a3tm1Dec mutation (1 available); any Col4a3 mutation (9 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• mice die between 23 and 30 weeks (J:167404)
• mice die between 23 and 30 weeks (J:167404)

renal/urinary system
• at 22 weeks (J:167404)
• at 22 weeks (J:167404)
• beginning at 12 weeks and extensive at 22 weeks (J:167404)
• beginning at 12 weeks and extensive at 22 weeks (J:167404)
• at 22 weeks (J:167404)
• at 22 weeks (J:167404)
• at 22 weeks, the glomerular basement membrane exhibits focal thinning and thickening compared to in wild-type mice (J:167404)
• at 22 weeks, the glomerular basement membrane exhibits focal thinning and thickening compared to in wild-type mice (J:167404)
• beginning at 12 weeks and extensive at 22 weeks (J:167404)
• beginning at 12 weeks and extensive at 22 weeks (J:167404)
• beginning at 12 weeks and extensive at 22 weeks, mice exhibit tubular atrophy unlike wild-type mice (J:167404)
• beginning at 12 weeks and extensive at 22 weeks, mice exhibit tubular atrophy unlike wild-type mice (J:167404)

homeostasis/metabolism
• at 22 weeks (J:167404)
• at 22 weeks (J:167404)
• at 22 weeks (J:167404)
• at 22 weeks (J:167404)

immune system
• beginning at 12 weeks and extensive at 22 weeks (J:167404)
• beginning at 12 weeks and extensive at 22 weeks (J:167404)




Genotype
MGI:3510446
hm4
Allelic
Composition
Col4a3tm1Dec/Col4a3tm1Dec
Genetic
Background
involves: 129X1/SvJ * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Col4a3tm1Dec mutation (1 available); any Col4a3 mutation (9 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• homozygotes die when end-stage renal disease develops at ~14 weeks of age (J:37963)
• homozygotes die when end-stage renal disease develops at ~14 weeks of age (J:37963)

homeostasis/metabolism
• blood urea nitrogen levels begin to rise at ~10 weeks, and show a 10-fold increase over wild-type levels at ~14 weeks (J:37963)
• blood urea nitrogen levels begin to rise at ~10 weeks, and show a 10-fold increase over wild-type levels at ~14 weeks (J:37963)
• homozygotes develop proteinuria at ~5 weeks (J:37963)
• the majority of protein is of a molecular size consistent with mouse serum albumin (J:37963)
• homozygotes develop proteinuria at ~5 weeks (J:37963)
• the majority of protein is of a molecular size consistent with mouse serum albumin (J:37963)
• as early as 2 weeks, homozygotes exhibit microhematuria which persists at relatively constant levels through the course of renal disease (J:37963)
• as early as 2 weeks, homozygotes exhibit microhematuria which persists at relatively constant levels through the course of renal disease (J:37963)

immune system
• homozygotes develop progressive glomerulonephritis and die with end-stage renal disease at ~14 weeks (J:37963)
• homozygotes develop progressive glomerulonephritis and die with end-stage renal disease at ~14 weeks (J:37963)

renal/urinary system
• at 8 weeks, homozygotes display thickened capillary walls with a rounded appearance (J:37963)
• by 14 weeks, half of the glomeruli are fibrotic with collapsed capillaries (J:37963)
• at 8 weeks, homozygotes display thickened capillary walls with a rounded appearance (J:37963)
• by 14 weeks, half of the glomeruli are fibrotic with collapsed capillaries (J:37963)
• homozygotes develop proteinuria at ~5 weeks (J:37963)
• the majority of protein is of a molecular size consistent with mouse serum albumin (J:37963)
• homozygotes develop proteinuria at ~5 weeks (J:37963)
• the majority of protein is of a molecular size consistent with mouse serum albumin (J:37963)
• as early as 2 weeks, homozygotes exhibit microhematuria which persists at relatively constant levels through the course of renal disease (J:37963)
• as early as 2 weeks, homozygotes exhibit microhematuria which persists at relatively constant levels through the course of renal disease (J:37963)
• homozygotes develop progressive glomerulonephritis and die with end-stage renal disease at ~14 weeks (J:37963)
• homozygotes develop progressive glomerulonephritis and die with end-stage renal disease at ~14 weeks (J:37963)
• at end-stage, localized obliteration of podocytes is quite common (J:37963)
• at end-stage, localized obliteration of podocytes is quite common (J:37963)
• at end-stage, pedicels are effaced (J:37963)
• at end-stage, pedicels are effaced (J:37963)
• at 4 weeks, homozygotes exhibit focal swelling and obliteration of the foot processes of podocytes (J:91619)
• at 4 weeks, homozygotes exhibit focal swelling and obliteration of the foot processes of podocytes (J:91619)
• by 8 weeks of age, an abundance of epithelial cell microvilli are observed (J:37963)
• by 8 weeks of age, an abundance of epithelial cell microvilli are observed (J:37963)
• the mutant GBM displays focal multilaminated thickening and thinning, beginning in the external capillary loops at 4 weeks and extending throughout the GBM by 8 weeks (J:37963)
• the mutant GBM displays focal multilaminated thickening and thinning, beginning in the external capillary loops at 4 weeks and extending throughout the GBM by 8 weeks (J:37963)
• at 4 weeks, mutants show a mild expansion of mesangial cells in most glomeruli (J:37963)
• at 4 weeks, mutants show a mild expansion of mesangial cells in most glomeruli (J:37963)
• at 4 weeks, mutants show a mild expansion of mesangial matrix in most glomeruli (J:37963)
• by end-stage, the mesangial matrix is grossly expanded and fibrotic (J:37963)
• at 4 weeks, mutants show a mild expansion of mesangial matrix in most glomeruli (J:37963)
• by end-stage, the mesangial matrix is grossly expanded and fibrotic (J:37963)
• by 14 weeks, half of the glomeruli are fibrotic (J:37963)
• by 14 weeks, half of the glomeruli are fibrotic (J:37963)
• by end-stage, the mutant kidney is 30-50% smaller by mass than that of wild-type mice (J:37963)
• by end-stage, the mutant kidney is 30-50% smaller by mass than that of wild-type mice (J:37963)
• at end-stage, the mutant kidney has a rough granular appearance (J:37963)
• at end-stage, the mutant kidney has a rough granular appearance (J:37963)
• at end-stage, the mutant kidney is pale (J:37963)
• at end-stage, the mutant kidney is pale (J:37963)

vision/eye
• in contrast to Alport patients, homozygotes do NOT display lenticonus; however, the interior layer of the basement membrane encasing the anterior lens is irregular instead of smooth (J:37963)
• in contrast to Alport patients, homozygotes do NOT display lenticonus; however, the interior layer of the basement membrane encasing the anterior lens is irregular instead of smooth (J:37963)

hearing/vestibular/ear
• COL4A5 chain is absent from all cochlear basement membranes except those in the vessels of the stria vascularis; in contrast, expression of COL4A1 and COL4A2 chains is unchanged (J:91619)
• homozygotes show significant thinning of the basement membrane running from the spiral limbus, down the inner sulcus, across the basilar membrane and up to the spiral prominence (J:91619)
• basement membranes that normally ensheathe the root cells are not detectable (J:91619)
• basement membranes surrounding the strial vessels are significantly thickened, with some degree of variation (J:91619)
• a greater abundance of COL4A1 and 4A2 chains and entactin is noted in strial basement membranes (J:91619)
• COL4A5 chain is absent from all cochlear basement membranes except those in the vessels of the stria vascularis; in contrast, expression of COL4A1 and COL4A2 chains is unchanged (J:91619)
• homozygotes show significant thinning of the basement membrane running from the spiral limbus, down the inner sulcus, across the basilar membrane and up to the spiral prominence (J:91619)
• basement membranes that normally ensheathe the root cells are not detectable (J:91619)
• basement membranes surrounding the strial vessels are significantly thickened, with some degree of variation (J:91619)
• a greater abundance of COL4A1 and 4A2 chains and entactin is noted in strial basement membranes (J:91619)
• homozygotes exhibit absence of the COL4A3 and COL4A4 chains throughout the membranous labyrinth (J:91619)
• homozygotes exhibit absence of the COL4A3 and COL4A4 chains throughout the membranous labyrinth (J:91619)
• basement membranes surrounding the strial vessels are significantly thickened, with some degree of variation (J:91619)
• at 5 weeks, mutant strial basement membranes are 1.6-3.1 thicker than normal, indicating that ultrastructural changes occur prior to the onset of uremia at ~12 weeks (J:91619)
• a greater abundance of COL4A1 and 4A2 chains and entactin is noted in strial basement membranes (J:91619)
• basement membranes surrounding the strial vessels are significantly thickened, with some degree of variation (J:91619)
• at 5 weeks, mutant strial basement membranes are 1.6-3.1 thicker than normal, indicating that ultrastructural changes occur prior to the onset of uremia at ~12 weeks (J:91619)
• a greater abundance of COL4A1 and 4A2 chains and entactin is noted in strial basement membranes (J:91619)
• endothelial cells lining the strial vessels are swollen and contain numerous vacuoles, resulting in capillaries with reduced internal diameters (J:91619)
• endothelial cells lining the strial vessels are swollen and contain numerous vacuoles, resulting in capillaries with reduced internal diameters (J:91619)
• homozygotes show variable changes in strial marginal cells, associated with enlarged, more rounded nuclei (J:91619)
• at 12-14 weeks, ~50% of mice with advanced glomerulonephritis show a reduction or loss of marginal cell basolateral infoldings (J:91619)
• homozygotes show variable changes in strial marginal cells, associated with enlarged, more rounded nuclei (J:91619)
• at 12-14 weeks, ~50% of mice with advanced glomerulonephritis show a reduction or loss of marginal cell basolateral infoldings (J:91619)

cardiovascular system
• at 8 weeks, homozygotes display thickened capillary walls with a rounded appearance (J:37963)
• by 14 weeks, half of the glomeruli are fibrotic with collapsed capillaries (J:37963)
• at 8 weeks, homozygotes display thickened capillary walls with a rounded appearance (J:37963)
• by 14 weeks, half of the glomeruli are fibrotic with collapsed capillaries (J:37963)
• endothelial cells lining the strial vessels are swollen and contain numerous vacuoles, resulting in capillaries with reduced internal diameters (J:91619)
• endothelial cells lining the strial vessels are swollen and contain numerous vacuoles, resulting in capillaries with reduced internal diameters (J:91619)

cellular
• COL4A5 chain is absent from all cochlear basement membranes except those in the vessels of the stria vascularis; in contrast, expression of COL4A1 and COL4A2 chains is unchanged (J:91619)
• homozygotes show significant thinning of the basement membrane running from the spiral limbus, down the inner sulcus, across the basilar membrane and up to the spiral prominence (J:91619)
• basement membranes that normally ensheathe the root cells are not detectable (J:91619)
• basement membranes surrounding the strial vessels are significantly thickened, with some degree of variation (J:91619)
• a greater abundance of COL4A1 and 4A2 chains and entactin is noted in strial basement membranes (J:91619)
• COL4A5 chain is absent from all cochlear basement membranes except those in the vessels of the stria vascularis; in contrast, expression of COL4A1 and COL4A2 chains is unchanged (J:91619)
• homozygotes show significant thinning of the basement membrane running from the spiral limbus, down the inner sulcus, across the basilar membrane and up to the spiral prominence (J:91619)
• basement membranes that normally ensheathe the root cells are not detectable (J:91619)
• basement membranes surrounding the strial vessels are significantly thickened, with some degree of variation (J:91619)
• a greater abundance of COL4A1 and 4A2 chains and entactin is noted in strial basement membranes (J:91619)

Mouse Models of Human Disease
OMIM ID Ref(s)
Alport Syndrome, Autosomal Recessive 203780 J:37963




Genotype
MGI:3583734
cx5
Allelic
Composition
Col4a3tm1Dec/Col4a3tm1Dec
Itga1tm1Gdnr/Itga1tm1Gdnr
Genetic
Background
involves: 129S4/SvJae * 129X1/SvJ * BALB/c
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Col4a3tm1Dec mutation (1 available); any Col4a3 mutation (9 available)
Itga1tm1Gdnr mutation (0 available); any Itga1 mutation (3 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
renal/urinary system
• decreased accumulation of myofibroblasts in kidneys of 7 week old mice compared to mice only homozygous for the collagen deficiency (J:71378)
• decreased accumulation of myofibroblasts in kidneys of 7 week old mice compared to mice only homozygous for the collagen deficiency (J:71378)
• infiltration of the kidney tubular interstitium by macrophage is less in 4 week old mice than in mice only homozygous for the collagen deficiency (J:71378)
• infiltration of the kidney tubular interstitium by macrophage is less in 4 week old mice than in mice only homozygous for the collagen deficiency (J:71378)
• attenuated damage to the glomerular basement membrane although damage still present (J:91620)
• attenuated damage to the glomerular basement membrane although damage still present (J:91620)
• slower rate of renal disease progression (J:91620)
• end stage renal failure delayed to 14.5 weeks rather than 8.5 weeks as in mice only homozygous for the collagen deficiency (J:91620)
• slower rate of renal disease progression (J:91620)
• end stage renal failure delayed to 14.5 weeks rather than 8.5 weeks as in mice only homozygous for the collagen deficiency (J:91620)

homeostasis/metabolism
• onset of proteinuria is delayed relative to mice only homozygous for the collagen deficiency (J:91620)
• onset of proteinuria is delayed relative to mice only homozygous for the collagen deficiency (J:91620)

immune system
• infiltration of the kidney tubular interstitium by macrophage is less in 4 week old mice than in mice only homozygous for the collagen deficiency (J:71378)
• infiltration of the kidney tubular interstitium by macrophage is less in 4 week old mice than in mice only homozygous for the collagen deficiency (J:71378)




Genotype
MGI:4452039
cx6
Allelic
Composition
Col4a3tm1Dec/Col4a3tm1Dec
Sostdc1tm1Myan/Sostdc1tm1Myan
Genetic
Background
involves: 129X1/SvJ
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Col4a3tm1Dec mutation (1 available); any Col4a3 mutation (9 available)
Sostdc1tm1Myan mutation (0 available); any Sostdc1 mutation (4 available)
phenotype observed in females
phenotype observed in males
N normal phenotype

Sostdc1tm1Myan/Sostdc1tm1Myan Col4a3tm1Dec/Col4a3tm1Dec mice show less glomerular and tubular injury than Col4a3tm1Dec/Col4a3tm1Dec mice

mortality/aging
• improved survival relative to Col4a3tm1Dec single homozygotes beyond 13 weeks of age (J:158731)
• improved survival relative to Col4a3tm1Dec single homozygotes beyond 13 weeks of age (J:158731)

renal/urinary system
• at 6 weeks of age have less severe albuminuria than in Col4a3tm1Dec single homozygotes (J:158731)
• at 6 weeks of age have less severe albuminuria than in Col4a3tm1Dec single homozygotes (J:158731)
• severity is less than in Col4a3tm1Dec single homozygotes (J:158731)
• severity is less than in Col4a3tm1Dec single homozygotes (J:158731)
• at 10 weeks of age mice demonstrate glomerulosclerosis associated with inflammatory cell infiltration, interstitial fibrosis, tubular atrophy, and cast formation severity is less than in Col4a3tm1Dec single homozygotes (J:158731)
• at 10 weeks of age mice demonstrate glomerulosclerosis associated with inflammatory cell infiltration, interstitial fibrosis, tubular atrophy, and cast formation severity is less than in Col4a3tm1Dec single homozygotes (J:158731)
• at 10 weeks of age mice demonstrate interstitial fibrosis that is less severe than in Col4a3tm1Dec single homozygotes (J:158731)
• at 10 weeks of age mice demonstrate interstitial fibrosis that is less severe than in Col4a3tm1Dec single homozygotes (J:158731)
• at 10 weeks of age mice demonstrate tubular atrophy that is less than in Col4a3tm1Dec single homozygotes (J:158731)
• at 10 weeks of age mice demonstrate tubular atrophy that is less than in Col4a3tm1Dec single homozygotes (J:158731)
• at 10 weeks of age mice demonstrate cast formation that is less severe than in Col4a3tm1Dec single homozygotes (J:158731)
• at 10 weeks of age mice demonstrate cast formation that is less severe than in Col4a3tm1Dec single homozygotes (J:158731)

immune system
• severity is less than in Col4a3tm1Dec single homozygotes (J:158731)
• severity is less than in Col4a3tm1Dec single homozygotes (J:158731)

homeostasis/metabolism
• at 10 weeks of age creatinine level is lower than in Col4a3tm1Dec single homozygotes (J:158731)
• at 10 weeks of age creatinine level is lower than in Col4a3tm1Dec single homozygotes (J:158731)
• at 10 weeks of age BUN is lower than in Col4a3tm1Dec single homozygotes (J:158731)
• at 10 weeks of age BUN is lower than in Col4a3tm1Dec single homozygotes (J:158731)
• at 6 weeks of age have less severe albuminuria than in Col4a3tm1Dec single homozygotes (J:158731)
• at 6 weeks of age have less severe albuminuria than in Col4a3tm1Dec single homozygotes (J:158731)

cardiovascular system
• compared to Col4a3tm1Dec single homozygotes at 5 weeks of age (J:158731)
• compared to Col4a3tm1Dec single homozygotes at 5 weeks of age (J:158731)





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Tumor Biology (MTB), Gene Ontology (GO), MouseCyc
Citing These Resources
Funding Information
Warranty Disclaimer & Copyright Notice
Send questions and comments to User Support.
last database update
02/02/2016
MGI 6.02
The Jackson Laboratory